PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

PAVmed Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 30, 2021 / 03:20PM GMT
Release Date Price: €90.49 (+1.41%)
Charles Duncan
Cantor Fitzgerald - Analyst

Hello, welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I am a Senior Biotechnology Analyst with the firm, and today is day 4 of this conference, and it's been a great conference and really a quite interesting year since we last hosted our clients in the fall of 2020.

So it's a pleasure to introduce the next presenting company, that is PAVmed. With me today, I'm joined by the Company's President and Chief Financial Officer, Dennis McGrath. Dennis, how are you doing today?

Dennis McGrath
PAVmed Inc. - President & CFO

Charles, I'm doing great. Thank you for having us, your firm, and to participate in this conference.

Charles Duncan
Cantor Fitzgerald - Analyst

Well, it's great to see you and really appreciate you sharing some of the PAVmed story with us. I see that you have some slides. So what I thought you could do is run through the story with us, kind of set the table. I'll probably interrupt or I will hold some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot